08/22/2018 12:00 AM EDT
The resources on this web page highlight relevant Food and Drug Administration (FDA) guidance and regulatory information about medical countermeasures (MCMs), specific FDA projects related to monitoring and assessment of MCMs, some of the ongoing FDA work related to medical product assessment in general, and key efforts relevant to MCMs that are ongoing outside of FDA.
08/22/2018 12:00 AM EDT
This web page provides information and documents about the Food and Drug Administration (FDA) Medical Countermeasures Initiative (MCMi) legal, regulatory, and policy framework that ensures that U.S. laws, regulations, and policies help support preparedness and response for potential chemical, biological, radiological, nuclear (CBRN), and emerging infectious disease threats. MCMi also helps facilitate advances in regulatory science available for practical use in the regulatory review process.
08/21/2018 12:00 AM EDT
This 21-page issue of The Dialogue, a quarterly technical assistance journal on disaster behavioral health, presents several articles reflecting the experiences of first responders, and highlights the challenges first responders face through all phases of disaster response. By focusing on resilience building and taking care of their behavioral health, first responders may avoid secondary or vicarious trauma and be better able to help their communities.
.png)
No hay comentarios:
Publicar un comentario